메뉴 건너뛰기




Volumn 101, Issue 4, 2009, Pages 770-772

Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AαIVS4+IG>T mutation and Aα4841 delC truncation (AαPerth)

Author keywords

[No Author keywords available]

Indexed keywords

BATROXOBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; FIBRINOGEN; GENOMIC DNA; GUANINE NUCLEOTIDE; PROTHROMBIN; PYRIMIDINE NUCLEOTIDE; THROMBIN; THROMBOPLASTIN;

EID: 64849113863     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-11-0777     Document Type: Article
Times cited : (13)

References (13)
  • 1
    • 28344448202 scopus 로고    scopus 로고
    • Fibrinogen and fibrin structure and functions
    • Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894-1904.
    • (2005) J Thromb Haemost , vol.3 , pp. 1894-1904
    • Mosesson, M.W.1
  • 2
    • 0036880584 scopus 로고    scopus 로고
    • Dysfibrinogenemia and thrombosis
    • Hayes T. Dysfibrinogenemia and thrombosis. Arch Pathol Lab Med 2002; 126: 1387-1390.
    • (2002) Arch Pathol Lab Med , vol.126 , pp. 1387-1390
    • Hayes, T.1
  • 4
    • 33748752527 scopus 로고    scopus 로고
    • The molecular basis of quantitative fibrinogen disorders
    • Asselta R, Duga S, Tenchini ML. The molecular basis of quantitative fibrinogen disorders. J Thromb Haemost 2006; 4: 2115-2129.
    • (2006) J Thromb Haemost , vol.4 , pp. 2115-2129
    • Asselta, R.1    Duga, S.2    Tenchini, M.L.3
  • 5
    • 0035869377 scopus 로고    scopus 로고
    • Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4+ 1 G-->T
    • Attanasio C, de Moerloose P, Antonarakis SE, et al. Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4+ 1 G-->T. Blood2001;97: 1879-1881.
    • Blood2001;97 , pp. 1879-1881
    • Attanasio, C.1    de Moerloose, P.2    Antonarakis, S.E.3
  • 6
    • 1642287922 scopus 로고    scopus 로고
    • Novel Aalpha chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerization
    • Homer VM, Mullin JL, Brennan SO, et al. Novel Aalpha chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerization. J Thromb Haemost 2003; 1: 1245-1250.
    • (2003) J Thromb Haemost , vol.1 , pp. 1245-1250
    • Homer, V.M.1    Mullin, J.L.2    Brennan, S.O.3
  • 7
    • 0037986620 scopus 로고    scopus 로고
    • Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: Effects on fibrin structure and function
    • Standeven KF, Grant PJ, Carter AM, et al. Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function. Circulation 2003; 107: 2326-2330.
    • (2003) Circulation , vol.107 , pp. 2326-2330
    • Standeven, K.F.1    Grant, P.J.2    Carter, A.M.3
  • 8
    • 35648978175 scopus 로고    scopus 로고
    • The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study
    • Rasmussen-Torvik LJ, Cushman M, Tsai MY, et al. The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study. Thromb Res 2007; 121: 1-7.
    • (2007) Thromb Res , vol.121 , pp. 1-7
    • Rasmussen-Torvik, L.J.1    Cushman, M.2    Tsai, M.Y.3
  • 9
    • 0030931417 scopus 로고    scopus 로고
    • Fibrinogen Otago: A major alpha chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage
    • Ridgway HJ, Brennan SO, Faed JM, et al. Fibrinogen Otago: a major alpha chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage. Br J Haematol 1997; 98: 632-639.
    • (1997) Br J Haematol , vol.98 , pp. 632-639
    • Ridgway, H.J.1    Brennan, S.O.2    Faed, J.M.3
  • 10
    • 0029985491 scopus 로고    scopus 로고
    • Fibrinogen Lincoln: A new truncated alpha chain variant with delayed clotting
    • Ridgway HJ, Brennan SO, Gibbons S, et al. Fibrinogen Lincoln: a new truncated alpha chain variant with delayed clotting. Br J Haematol 1996; 93: 177-184.
    • (1996) Br J Haematol , vol.93 , pp. 177-184
    • Ridgway, H.J.1    Brennan, S.O.2    Gibbons, S.3
  • 11
    • 33746683106 scopus 로고    scopus 로고
    • Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aalpha chain truncation causing decreased plasma expression and impaired fibrin polymerisation
    • Brennan SO, Mosesson MW, Lowen R, et al. Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aalpha chain truncation causing decreased plasma expression and impaired fibrin polymerisation. Thromb Haemost 2006; 96: 88-89.
    • (2006) Thromb Haemost , vol.96 , pp. 88-89
    • Brennan, S.O.1    Mosesson, M.W.2    Lowen, R.3
  • 12
    • 0026785207 scopus 로고
    • Fibrinogen Marburg: A homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA)
    • Koopman J, Haverkate F, Grimbergen J, et al. Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA). Blood 1992; 80: 1972-1979.
    • (1992) Blood , vol.80 , pp. 1972-1979
    • Koopman, J.1    Haverkate, F.2    Grimbergen, J.3
  • 13
    • 1642345132 scopus 로고    scopus 로고
    • Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS4 + 1G>T mutation and anAalphaGln328 truncation (fibrinogen Keokuk)
    • Lefebvre P, Velasco PT, Dear A, et al. Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS4 + 1G>T mutation and anAalphaGln328 truncation (fibrinogen Keokuk). Blood 2004; 103: 2571-2576.
    • (2004) Blood , vol.103 , pp. 2571-2576
    • Lefebvre, P.1    Velasco, P.T.2    Dear, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.